C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study
Authors
Keywords
Body Mass Index, Breast Cancer Risk, Menopausal Status, Postmenopausal Breast Cancer, Excess Body Weight
Journal
CANCER CAUSES & CONTROL
Volume 25, Issue 4, Pages 533-539
Publisher
Springer Nature
Online
2014-02-06
DOI
10.1007/s10552-014-0355-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Prospective Study of Circulating C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor α Receptor 2 Levels and Risk of Ovarian Cancer
- (2013) Elizabeth M. Poole et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Association Between C-reactive Protein and Risk of Cancer: A Meta-analysis of Prospective Cohort Studies
- (2013) Yong-Zhong Guo et al. Asian Pacific Journal of Cancer Prevention
- Preoperative Serum C-Reactive Protein Levels and Early Breast Cancer by BMI and Menopausal Status
- (2013) Tingting Hong et al. CANCER INVESTIGATION
- Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer
- (2013) N. J. Ollberding et al. Cancer Prevention Research
- Association Between Prediagnostic Biomarkers of Inflammation and Endothelial Function and Cancer Risk: A Nested Case-Control Study
- (2012) M. Touvier et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
- (2012) Giorgio Trinchieri Annual Review of Immunology
- Dietary factors and low-grade inflammation in relation to overweight and obesity
- (2011) Philip C. Calder et al. BRITISH JOURNAL OF NUTRITION
- Association between Levels of C-Reactive Protein and Leukocytes and Cancer: Three Repeated Measurements in the Swedish AMORIS Study
- (2011) M. Van Hemelrijck et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Prospective Study of Inflammation Markers and Endometrial Cancer Risk in Postmenopausal Hormone Nonusers
- (2011) T. Wang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study
- (2010) Laure Dossus et al. ENDOCRINE-RELATED CANCER
- C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies
- (2010) Katriina Heikkilä et al. EUROPEAN JOURNAL OF CANCER
- C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
- (2010) Kristine H. Allin et al. JNCI-Journal of the National Cancer Institute
- Adiponectin and breast cancer
- (2010) Xiuping Chen et al. MEDICAL ONCOLOGY
- C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy)
- (2009) Eva Lundin et al. CANCER CAUSES & CONTROL
- Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
- (2009) Kristine H. Allin et al. JOURNAL OF CLINICAL ONCOLOGY
- Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
- (2008) Katriina Heikkilä et al. CANCER CAUSES & CONTROL
- Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study
- (2008) R. J. Glynn et al. CLINICAL CHEMISTRY
- Re: C-Reactive Protein and Risk of Breast Cancer
- (2008) A. Zeleniuch-Jacquotte et al. JNCI-Journal of the National Cancer Institute
- The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective
- (2008) Martin Wiseman PROCEEDINGS OF THE NUTRITION SOCIETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started